BIODESIX INC
Biodesix, Inc (BDSX) is a US-based diagnostics company that develops blood‑based proteomic tests and data analytics for lung disease and oncology. Its products aim to help clinicians improve diagnostic accuracy and treatment decisions through machine‑learning enabled assays and commercial partnerships. With a market capitalisation of roughly $50 million, Biodesix is a small‑cap, early‑stage healthcare company, which typically brings higher volatility, lower liquidity and greater sensitivity to clinical, reimbursement and funding outcomes. Potential upside drivers include wider clinical adoption of its assays, favourable reimbursement decisions and collaborations with providers or pharmaceutical firms. Key risks include limited revenue scale, cash burn that may require future financing, regulatory or clinical setbacks, and competitive alternatives. This information is educational only and not investment advice; investors should assess their risk tolerance, review company filings and consult a financial adviser before considering any position.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Biodesix's stock, expecting its price to rise significantly.
Financial Health
Biodesix is achieving strong profits and revenue while maintaining healthy cash flow and margins.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring BDSX
Liquid-Biopsy Diagnostics
These innovative companies are developing revolutionary blood tests that can detect cancer earlier and more accurately than ever before. Carefully selected by healthcare investment experts, this collection represents the forefront of non-invasive diagnostics poised to transform the multi-billion dollar oncology market.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Commercial adoption watch
Investors may watch test uptake and reimbursement; these drive revenue growth, though adoption can be slower than expected and affect results.
Technology and data
Proteomics plus machine learning underpin the offering and could differentiate products, but robust clinical validation is essential.
Partners and scale
Partnerships with hospitals and pharma can extend reach and credibility, yet competitive pressures and payment systems can limit impact.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Chemed Corp.
Provides hospice and palliative care services to patients facing life-limiting illness
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale Senior Living Inc.
A leading owner and operator of senior living communities in the United States.
